Related Experiment Video

Updated: Jun 10, 2025

Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

11.2K

Assessing the inclusion of postinflammatory hyperpigmentation outcomes in acne vulgaris clinical trials

Alyssa Swearingen1, Christine Olagun-Samuel2, Arielle R Nagler2

  • 1Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York; Rutgers New Jersey Medical School, Newark, New Jersey.

Journal of the American Academy of Dermatology
|October 11, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
acne vulgarisacne-induced hyperpigmentationclinical trialsoutcome measurespostinflammatory hyperpigmentationprimary outcomessecondary outcomesskin of color

More Related Videos

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

804
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

814

Related Experiment Videos

Last Updated: Jun 10, 2025

Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

11.2K
Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
03:47

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

Published on: September 27, 2024

804
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

814

Related Concept Videos

Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

1.7K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
1.7K
Skin Cancer01:30

Skin Cancer

3.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.9K

Articles linked to this work by shared authors, journal, and citation graph.

Best Practices for Managing Pseudofolliculitis Barbae: An Expert Consensus Delphi Study.

JAMA dermatology·2026

Complement fragment 4d staining as a potential diagnostic tool for bullous disorders with esophageal involvement.

Dermatology online journal·2026

Psychiatric Comorbidities in Pseudofolliculitis Barbae: A Cross-Sectional Study of the All of Us Database.

Skin appendage disorders·2026

Integrating Patient-Reported Outcome Measures in Atopic Dermatitis Clinical Practice: An Analysis of the Patient-Oriented Eczema Measure.

Pediatric dermatology·2026

Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review.

Journal of drugs in dermatology : JDD·2026

Internet and Social Media Use Among Patients with Hair and Scalp Disorders: A Behavioral Analysis.

Dermatology practical & conceptual·2026

Sonelokimab, a novel IL-17A- and IL-17F-inhibiting nanobody for the treatment of moderate-to-severe hidradenitis suppurativa: a global, randomized, double-blind, placebo-controlled phase 2 clinical trial (MIRA).

Journal of the American Academy of Dermatology·2026

Geospatial approaches to analysing spatial patterns of stroke incidence and mortality: a systematic review.

Geospatial health·2026

Trial and error: a mapping review of operative and perioperative strategies to reduce post-appendicectomy abdominal infection.

Annals of the Royal College of Surgeons of England·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us